Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10195640rdf:typepubmed:Citationlld:pubmed
pubmed-article:10195640lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:10195640lifeskim:mentionsumls-concept:C0014372lld:lifeskim
pubmed-article:10195640lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:10195640lifeskim:mentionsumls-concept:C0018837lld:lifeskim
pubmed-article:10195640lifeskim:mentionsumls-concept:C1527177lld:lifeskim
pubmed-article:10195640lifeskim:mentionsumls-concept:C0441513lld:lifeskim
pubmed-article:10195640lifeskim:mentionsumls-concept:C1711351lld:lifeskim
pubmed-article:10195640lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:10195640pubmed:issue9-10lld:pubmed
pubmed-article:10195640pubmed:dateCreated1999-6-2lld:pubmed
pubmed-article:10195640pubmed:abstractTextThree recombinant strains of Mycobacterium bovis Bacille Calmette Guerin (rBCG) were prepared in which the immunogenic B subunit of human Escherichia coli heat labile enterotoxin (LT-Bh) was expressed either as a cytoplasm protein, a cell wall associated lipoprotein or a secreted protein. Intraperitoneal immunisation of mice with these rBCG induced IgG and IgA antibodies to LT-Bh and shifted the serum IgG subclass response to subsequent challenge with purified LT-Bh from IgG1 to an IgG2a. Oral administration of recombinant BCG induced mucosal and serum IgA antibodies to LT-Bh which peaked four months after immunisation. Antibody responses were greater when LT-Bh was expressed as a secreted protein or lipoprotein rather than in the cytoplasm. Oral vaccination with recombinant BCG may be an effective approach, particularly to induce mucosal IgA and prime for a serum TH1 recall response.lld:pubmed
pubmed-article:10195640pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195640pubmed:languageenglld:pubmed
pubmed-article:10195640pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195640pubmed:citationSubsetIMlld:pubmed
pubmed-article:10195640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195640pubmed:statusMEDLINElld:pubmed
pubmed-article:10195640pubmed:monthMarlld:pubmed
pubmed-article:10195640pubmed:issn0264-410Xlld:pubmed
pubmed-article:10195640pubmed:authorpubmed-author:YoungD BDBlld:pubmed
pubmed-article:10195640pubmed:authorpubmed-author:LewisD JDJlld:pubmed
pubmed-article:10195640pubmed:authorpubmed-author:HaywardC MCMlld:pubmed
pubmed-article:10195640pubmed:authorpubmed-author:GriffinG EGElld:pubmed
pubmed-article:10195640pubmed:authorpubmed-author:HirstT RTRlld:pubmed
pubmed-article:10195640pubmed:authorpubmed-author:O'GaoraPPlld:pubmed
pubmed-article:10195640pubmed:authorpubmed-author:TholeJJlld:pubmed
pubmed-article:10195640pubmed:authorpubmed-author:Castello-Bran...lld:pubmed
pubmed-article:10195640pubmed:issnTypePrintlld:pubmed
pubmed-article:10195640pubmed:day5lld:pubmed
pubmed-article:10195640pubmed:volume17lld:pubmed
pubmed-article:10195640pubmed:ownerNLMlld:pubmed
pubmed-article:10195640pubmed:authorsCompleteYlld:pubmed
pubmed-article:10195640pubmed:pagination1272-81lld:pubmed
pubmed-article:10195640pubmed:dateRevised2009-9-29lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:meshHeadingpubmed-meshheading:10195640...lld:pubmed
pubmed-article:10195640pubmed:year1999lld:pubmed
pubmed-article:10195640pubmed:articleTitleConstruction and murine immunogenicity of recombinant Bacille Calmette Guérin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin.lld:pubmed
pubmed-article:10195640pubmed:affiliationDivision of Infectious Diseases, St. George's Hospital Medical School, London, UK.lld:pubmed
pubmed-article:10195640pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10195640pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10195640lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10195640lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10195640lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10195640lld:pubmed